Characteristics of COVID-19 patients refractory to therapy

April 02, 2020

Share article

The authors were interested in the characteristics of patients with refractory COVID-19. They conducted a retrospective study in which 155 consecutive patients with confirmed COVID-19 in Zhongnan Hospital, Wuhan were divided into general and refractory COVID-19 groups. Compared with general COVID-19 patients (45.2%), refractory patients were older, male and were more likely to have underlying comorbidities. They also had a lower incidence of fever but higher maximal fevers; higher incidence of shortness of breath and anorexia; worse disease assessments on admission; higher levels of neutrophils, AST, LDH and CRP; lower levels of platelets and albumin; and a higher incidence of bilateral pneumonia and pleural effusion. Refractory COVID-19 patients were more likely to receive oxygen, mechanical ventilation, expectorants and adjunct therapies, including corticosteroids, antivirals and immune enhancers. Therefore nearly 50% COVID-19 patients did not achieve remission within 10 days of hospitalisation. Patients with male sex, anorexia and no fever on admission predicted poor response to therapy.

Read more here

Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, et al. ISSN: Clin Infect Dis; pii: ciaa270


Added: April 02, 2020